Close Menu

NEW YORK – Investment bank BTIG has initiated coverage of CareDx's stock with a Buy rating and a price target of $40.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.